IA
FLXN

IFP Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

IFP Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-56
Closed -$1K – 3551
2021
Q3 		$1K Buy
+56
New +$349 ﹤0.01% 3209
2019
Q1 		– Sell
-175
Closed -$2K – 3701
2018
Q4 		$2K Sell
175
-1,500
-90% -$23.5K ﹤0.01% 3230
2018
Q3 		$31K Sell
1,675
-3,680
-69% -$84.6K ﹤0.01% 2196
2018
Q2 		$138K Sell
5,355
-3,650
-41% -$94.7K 0.01% 1302
2018
Q1 		$225K Hold
9,005
– – 0.01% 935
2017
Q4 		$225K Buy
9,005
+975
+12% +$23.9K 0.01% 937
2017
Q3 		$194K Buy
8,030
+2,950
+58% +$69.3K 0.01% 1165
2017
Q2 		$103K Buy
5,080
+1,500
+42% +$31.2K ﹤0.01% 1514
2017
Q1 		$96K Sell
3,580
-70
-2% -$1.43K ﹤0.01% 1513
2016
Q4 		$69K Buy
3,650
+1,650
+83% +$31.5K ﹤0.01% 1689
2016
Q3 		$39K Buy
+2,000
New +$33.8K ﹤0.01% 1975

IFP Advisors's FLXN Position: Q4 2021 in Review

IFP Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 56 shares — an estimated $1K sold.

IFP Advisors first reported a position in FLXN in Q3 2016 and held it in 11 quarters. The position peaked at $225K in Q1 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • IFP Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • IFP Advisors sold 56 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $1K.
  • IFP Advisors first reported a position in Flexion Therapeutics, Inc. in Q3 2016 and held it in 11 quarters.
  • IFP Advisors's Flexion Therapeutics, Inc. position peaked at $225K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on IFP Advisors's 13F filing for Q4 2021, filed 12 Jan 2022.